Hess KR - Search Results

1

Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer.

Liedtke C, Mazouni C, Hess KR, André F, Tordai A, Mejia JA, Symmans WF, Gonzalez-Angulo AM, Hennessy B, Green M, Cristofanilli M, Hortobagyi GN, Pusztai L. Liedtke C, et al. Among authors: hess kr. J Clin Oncol. 2008 Mar 10;26(8):1275-81. doi: 10.1200/JCO.2007.14.4147. Epub 2008 Feb 4. J Clin Oncol. 2008. PMID: 18250347

2

Analysis of a diagnostic strategy for patients with suspected tumors of unknown origin.

Abbruzzese JL, Abbruzzese MC, Lenzi R, Hess KR, Raber MN. Abbruzzese JL, et al. Among authors: hess kr. J Clin Oncol. 1995 Aug;13(8):2094-103. doi: 10.1200/JCO.1995.13.8.2094. J Clin Oncol. 1995. PMID: 7636553

3

Primary adenocarcinoma of the duodenum: management and survival in 67 patients.

Barnes G Jr, Romero L, Hess KR, Curley SA. Barnes G Jr, et al. Among authors: hess kr. Ann Surg Oncol. 1994 Jan;1(1):73-8. doi: 10.1007/BF02303544. Ann Surg Oncol. 1994. PMID: 7834432

4

Unknown primary carcinoma: natural history and prognostic factors in 657 consecutive patients.

Abbruzzese JL, Abbruzzese MC, Hess KR, Raber MN, Lenzi R, Frost P. Abbruzzese JL, et al. Among authors: hess kr. J Clin Oncol. 1994 Jun;12(6):1272-80. doi: 10.1200/JCO.1994.12.6.1272. J Clin Oncol. 1994. PMID: 8201389

5

Impact of adjuvant mitotane on the clinical course of patients with adrenocortical cancer.

Vassilopoulou-Sellin R, Guinee VF, Klein MJ, Taylor SH, Hess KR, Schultz PN, Samaan NA. Vassilopoulou-Sellin R, et al. Among authors: hess kr. Cancer. 1993 May 15;71(10):3119-23. doi: 10.1002/1097-0142(19930515)71:10<3119::aid-cncr2820711037>3.0.co;2-8. Cancer. 1993. PMID: 8490842

6

TPDC-FuHu chemotherapy for the treatment of recurrent metastatic brain tumors.

Kaba SE, Kyritsis AP, Hess K, Yung WK, Mercier R, Dakhil S, Jaeckle KA, Levin VA. Kaba SE, et al. J Clin Oncol. 1997 Mar;15(3):1063-70. doi: 10.1200/JCO.1997.15.3.1063. J Clin Oncol. 1997. PMID: 9060546 Clinical Trial.

7

Poorly differentiated carcinoma and poorly differentiated adenocarcinoma of unknown origin: favorable subsets of patients with unknown-primary carcinoma?

Lenzi R, Hess KR, Abbruzzese MC, Raber MN, Ordoñez NG, Abbruzzese JL. Lenzi R, et al. Among authors: hess kr. J Clin Oncol. 1997 May;15(5):2056-66. doi: 10.1200/JCO.1997.15.5.2056. J Clin Oncol. 1997. PMID: 9164218

8

Role of surgery in the treatment of brain metastases in patients with breast cancer.

Pieper DR, Hess KR, Sawaya RE. Pieper DR, et al. Among authors: hess kr. Ann Surg Oncol. 1997 Sep;4(6):481-90. doi: 10.1007/BF02303672. Ann Surg Oncol. 1997. PMID: 9309337

9

Unknown primary tumors metastatic to liver.

Ayoub JP, Hess KR, Abbruzzese MC, Lenzi R, Raber MN, Abbruzzese JL. Ayoub JP, et al. Among authors: hess kr. J Clin Oncol. 1998 Jun;16(6):2105-12. doi: 10.1200/JCO.1998.16.6.2105. J Clin Oncol. 1998. PMID: 9626210

10

p53 immunohistochemical staining predicts residual disease after chemoradiation in patients with high-risk rectal cancer.

Spitz FR, Giacco GG, Hess K, Larry L, Rich TA, Janjan N, Cleary KR, Skibber JM. Spitz FR, et al. Among authors: hess k. Clin Cancer Res. 1997 Oct;3(10):1685-90. Clin Cancer Res. 1997. PMID: 9815551

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

419 results

Search Page

Filters